Literature DB >> 33692116

Slowing Progression in CKD: DAPA CKD and Beyond.

Kathryn Larmour1, Adeera Levin2.   

Abstract

Entities:  

Keywords:  CKD; MRA chronic kidney disease; SGLT2i; delay; evidence; progression

Mesh：

Substances：

Year:  2021        PMID： 33692116      PMCID： PMC8425615          DOI： 10.2215/CJN.20211220

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  2 in total

1.  A real-world study on SGLT2 inhibitors and diabetic kidney disease progression.

Authors:  Allen Yan Lun Liu; Serena Low; Ester Yeoh; Eng Kuang Lim; Claude Jeffrey Renaud; Selene Tse Yen Teoh; Grace Feng Ling Tan; Chung Cheen Chai; Bo Liu; Tavintharan Subramaniam; Chee Fang Sum; Su Chi Lim
Journal:  Clin Kidney J       Date:  2022-02-16

2.  Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease.

Authors:  Esben Iversen; Thomas Kallemose; Mads Hornum; Anne Kathrine Bengaard; Jan Olof Nehlin; Line Jee Hartmann Rasmussen; Haakon Sandholdt; Juliette Tavenier; Bo Feldt-Rasmussen; Ove Andersen; Jesper Eugen-Olsen; Morten Baltzer Houlind
Journal:  Clin Kidney J       Date:  2022-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.